Tenidap - Pfizer
Alternative Names: CP 66248; CP 66248 2; Enable; Enablex® - Rheumatoid arthritis; Kenida®; Reumaten; TenedacLatest Information Update: 25 Mar 1998
At a glance
- Originator Pfizer
- Developer Pfizer; Roerig Farmaceutici
- Class Anti-inflammatories; Antirheumatics; Indoles
- Mechanism of Action Cyclooxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Registered Rheumatoid arthritis
- Discontinued HIV infections; Osteoarthritis